Background: Spontaneous clearance occurs in varying proportions in individuals infected by hepatitis C virus (HCV). However, the factors associated with this clearance are debatable. Their recognition may lead to a better understanding of HCV natural history and eventually improve associated prediction and management models. Aim: This study was conducted to determine the host-related factors associated with persistence of HCV infection.
Background
Hepatitis C virus (HCV) infection is an escalating global health problem. It is endemic in many countries and imposes a growing burden on society and health-care systems [1] . HCV prevalence in the Eastern Mediterranean Region is heterogeneous, with at least 23 million people estimated to have HCV infection. The prevalence ranges from 1% to 2.5% in most countries [2] , with higher prevalence reported in Egypt (10%) [3] and Libyan Arab Jamahiriya, Sudan, and Yemen (2.5%-10%) [4] .
The natural course of HCV infection is highly variable and ranges from asymptomatic silent infection to fulminating liver disease usually occurring over decades [5] . Acute HCV is heralded by detectable HCV-RNA in serum, usually followed by an antibody response directed against various structural and nonstructural viral proteins [6] . Chronic HCV is marked by viral persistence for at least 6 months despite the presence of a humoral immune response. Recovery or spontaneous clearance is defined by the presence of HCV-specific antibodies (anti-HCV) in the absence of detectable HCV-RNA [7] . Published studies have estimated the proportion of spontaneous viral clearance to be 19.8%, 27.9%, 36.1%, and 37.1% within 3, 6, 12, and 24 months of the onset of infection, respectively [8] .
Although the predictors of HCV clearance remain poorly elucidated, host-related factors including gender [8] and immune response [9] and viral factors such as HCV genotype and quasispecies diversity [10] appear to be relevant. Published findings suggest that previous HCV clearance can provide some protection against persistent reinfection [11] . Host genetics play an important role in HCV clearance, and the strongest host-related factor associated with HCV clearance is favorable interleukin 28B gene polymorphism [12] .
A major feature of HCV is the interindividual variability in the ability to clear the virus, either spontaneously or after treatment [13] . Knowledge of the variation between population subgroups in terms of the prevalence of spontaneous clearance could inform policy decisions on the use of direct-acting antivirals [8] . If individuals who will spontaneously clear the HCV infection can be identified beforehand, unnecessary antiviral treatment can be avoided and antiviral therapy can be promptly initiated to achieve a high sustained virologic response in those having a high risk of chronic HCV infection [14] .
Egypt has the highest worldwide prevalence of HCV infection, and the prevalence rises steeply with age. Anti-HCV antibodies are detected in 2%-7% of children under the age of 10 years, approximately 10% of individuals between the ages of 10 and 20 years, and more than half of those between the ages of 40 and 50 years in rural areas in the Nile Delta region [15] . Although there have been advances in HCV treatment modalities, the therapeutic response is highly variable. Currently, no HCV vaccine is available; therefore, it is critical to identify the factors associated with spontaneous resolution or viral clearance in infected individuals. An improved understanding of the predictors of spontaneous clearance is required to guide public health strategies for HCV control at both the prevention and therapy levels [16] .
Therefore, the present study is aimed at estimating the frequency and distribution of HCV spontaneous clearance rates and defining some host-related factors prevailing in Egypt.
Methods

Data collection and study population
An HCV cross-sectional survey study covering most Egyptian governorates was considered [17] . From the study cases, a simple random sample of anti-HCV positive cases was selected to study some host-factors related to the persistence of infection. For the current research, the sample size was calculated to be 482 using a 95% two-sided significance level and 90% power. All the data pertaining to anti-HCV positive individuals were collected in a single file for further computerized random sampling in the current research. The inclusion criteria were as follows: Anti-HCV positive individuals, at least 18-years-old, and had consented to participate. The exclusion criteria were as follows: Individuals who were currently receiving or had previously received HCV treatment, whose data were incomplete, or who refused to participate. The participants were interviewed by a trained interviewer using a standardized questionnaire [18] , which comprised inquiries about socio-demographic data, medical history, and behavioral, envi-ronmental, or other factors that could contribute to the acquisition of HCV infection.
Laboratory analysis
All the individuals included in this study showed confirmed serologic evidence of positive HCV antibodies. Anti-HCV detection in serum was carried out using a commercial enzyme-linked immunosorbent assay (third-generation ELISA kit; DIALAB1, Austria). A second serum sample was retested using another ELISA kit (DiaSorin Murex 1, version 4.0, Italy) for confirmation. All the blood samples were tested for viremia using quantitative real-time polymerase chain reaction (PCR).
Definitions
Clearance of infection was defined as the presence of serologic evidence of HCV infection (confirmed positive HCV-Ab results) in the absence of viremia (negative PCR results). On the other hand, persistence of infection was defined as the presence of viremia in HCV serological positive cases (positive HCV-Ab and positive PCR results).
Statistical analysis
Data were revised, entered, and analyzed using the statistical software SPSS IBM version 20. All the statistical analyses were carried out using twotailed tests and an alpha error of 0.05. The rates of spontaneous clearance and persistence of infection were calculated as the percentage of PCR-negative and PCR-positive individuals in the total population, respectively. Descriptive statistics in the form of frequencies and percentages were used to describe categorical data. The range, mean, and standard deviation were used to describe continuous data. Pearson chi-square tests were performed to examine the association between the studied factors and the rate of HCV clearance. Data were cross-tabulated against the dependent binary variable, i.e., PCR results. To examine the association between the studied factors and HCV-PCR positive status in the bivariate analysis, the odds ratio (OR) and 95% confidence interval (CI) were computed. A multivariate stepwise logistic regression model was created, and 22 factors were included regardless of their significance in the univariate analysis using a backward stepwise method.
Ethical statement
The present study was approved by the ethics committee of the High Institute of Public Health, Alexandria University (Egypt). The research strictly followed the ethical guidelines of the Declaration of Helsinki (2013) and the guidelines for Good Clinical Practice of the International Conference on Harmonization. Informed written consent was obtained from all the invited participants after the study aim and concerns
Results
The total number of subjects included in this study was expanded to 1059 HCV-Ab-positive individuals recruited from 16 different governorates (Table 1) ; among these individuals, 79% were living in rural areas. Their ages ranged between 18 and 75 years with a mean age of 49.4. Females constituted 53.5% of the studied population.
The number of individuals who were PCR negative was 257; thus, the rates of spontaneous clearance and persistence of infection were 24.3% and 75.7%, respectively. The rate of spontaneous clearance was significantly higher among females ( Table 2 and Table  3 , respectively.
The independent factors that increased the probability of HCV persistence were a history of incarceration of infrequent repeated RNA testing. It was found that HCV-RNA might be transiently undetectable in an infected patient even when the virus is still present in the liver and peripheral blood mononuclear cells [23] . Nevertheless, Takaki, et al. [24] indicated that humoral immunity might be progressively lost in patients who had recovered from HCV infection spontaneously.
Several epidemiologic studies have tried to identify the host-related factors determining spontaneous clearance with respect to the factors determining viral persistence, but the results have often been conflicting [25] . In the present research, younger participants (< 45 years) had a significantly higher rate of viral clearance than the older participants (> 45 years) (31% vs. 22.2%, respectively). The above results are supported by the results of many published reports, which found that young age was one of the host-related factors associated with spontaneous clearance of HCV infection [26] probably because younger people have a more vigorous immune response to viral infection [27] .
In the present study, female participants cleared the virus spontaneously more frequently than males (27.7% vs. 20.3%, respectively), which is similar to the observations made in other studies [21] . Esmat, et al.
(OR = 3.67, CI = 1.24-10.85), jaundice (OR = 1.54, CI = 0.95-2.49), unexplained fatigue during the last 6 months (OR = 1.42, CI = 1.03-1.95), and frequent dentist visits (OR = 1.17, CI = 1.08-1.26). The factor associated with a lower risk of persistent infection was previous blood sampling (OR = 0.4, CI = 0.19-0.87).
Discussion
This study aimed to detect the frequency of spontaneous clearance of HCV in Egypt and determine the host-related predictors of persistence of HCV. The results revealed that out of 1059 anti-HCV positive individuals (who denied receiving HCV antiviral treatment), 257 (24.3%) spontaneously cleared the virus (negative RNA). This finding matched previous results that indicated that on average, the recovery rate concerning acute HCV infection was close to 20% [19] . Similarly, published data pertaining to a population at risk of exposure indicated that 14%-40% of the people infected with HCV spontaneously cleared the virus [20] . Other studies reported even higher rates of at least 50% spontaneous clearance of HCV in various populations [21] . Seeff and Hoofnagle [22] reported that the rates of clearance differed according to the type of study, duration of follow up, and population selected for the study. and thereby result in a chronic persistent infection. The above justification is supported by the results of the present work as well as other study [37] .
Published data support the strategy of starting early treatment for high-risk groups that are less likely to achieve spontaneous clearance because these groups pose a higher risk of transmitting the virus to the community and may be more likely to be missed in follow-ups [8] . In the present research, incarceration was one of the four main independent factors significantly associated with the persistence of HCV infection. The significant association of a positive history of incarceration with HCV persistence could be attributed to risky behavior such as drug abuse, alcohol consumption, smoking, and abnormal sexual practices, which make the inmates vulnerable to chronic and communicable diseases. Moreover, inmates suffer from poor nutrition and lack of preventive care [38] . Intravenous drug abusers were considered to be a risk group that was less likely to achieve spontaneous clearance of HCV infection. Accordingly, intravenous drug abuse was reported to be negatively associated with spontaneous clearance of HCV [8] . This group-and other similar groups vulnerable to repeated exposures-does clear the virus but is reinfected with distinct HCV strains, which could have a significant effect on immune functions, thereby hindering spontaneous clearance.
Unlike in other studies, in this study, neither alcohol consumption nor tobacco and cannabis smoking demonstrated significant risks for viral persistence. These factors were reported to have several immunosuppressive effects and were found to lead to persistent infection because of an increase in fibrosis in patients with chronic HCV infection [39, 40] .
Conclusion
In Egypt, HCV spontaneous clearance occurs at a rate of 24.3%. Females and young individuals (< 45 years) have higher clearance rates. Host-related predictors of HCV persistence of infection are related to either risk factors associated with repeated infection (parenteral antischistosomal therapy, frequent dentist visits, high-risk occupations, and incarceration) or symptoms of chronic infection, particularly jaundice and fatigue with undetermined causes.
Limitations
The original survey for which we recruited the participants was a community-based cross-sectional multicenter study. Therefore, it was not feasible to carry out follow-ups with the participants 6 months later to ensure persistence using PCR. However, this drawback was compensated by increasing the sample size and its power, particularly considering that HCV is a silent disease wherein the acute infection is very hard to detect in both clinical and research settings unless a longitudi- [28] even recommended that female children should be given the opportunity to clear their infection. This variation might be due to the larger effect of the IL28B and HCV genotypes on viral clearance among females than among males or due to a gender difference in immunity [10] . There is considerable evidence that suggests that sex hormones influence immunity [8] , and the estrogen receptor alpha ESR2rs4986938AA genotype was found to be strongly associated with HCV clearance among the Chinese population [29] .
The effect of coinfection, particularly with hepatitis B virus (HBV) and Schistosoma, on HCV clearance is a matter of debate [30] . In the current study, only schistosomiasis coinfection was studied, and the results showed a 43% increase in the risk of persistence of infection. Some studies found that Schistosoma infection had no negative effect on HCV-specific cell-mediated immunity [31] and eventually no influence on viral clearance [28] . However, other studies found that the infection had a significant effect on host immune reactions including cytokine patterns and cytotoxic T lymphocyte responses [32] ; the case of coinfection resulted in a diminished virus clearance capacity, a higher viral load, greater morbidity and mortality, and failure to treatment [33] in comparison to the case of HCV infection alone.
A history of acute icteric hepatitis after inoculation has been frequently demonstrated to be associated with spontaneous viral clearance. It is speculated that persons with a strong basal immune response are likely to contract jaundice and hence have a better likelihood of eradicating the HCV and controlling the infection [34] . In contrast, a positive history of jaundice among our participants was one of the independent predictors for the persistence of HCV infection (OR = 1.54). In the present study, the history of jaundice is not necessarily a symptom in the case of acute infection, but jaundice is most probably due to liver insult late in the course of the disease or less probably a symptom of hepatitis A infection, which is endemic in Egypt.
Other independent predictors for persistent HCV were elicited from our work. These were a positive history of fatigue (OR = 1.42), dental manipulation (OR = 1.17), and incarceration (OR = 3.67). The above findings matched well with those documented by El-Attar, et al. [19] , who found that the symptoms of fatigue, bleeding, and epistaxis were more common in subjects who did not clear the infection. Similarly, Hoofnagle [35] concluded that most patients with persistent HCV infection showed a few common symptoms, with the most common being fatigue.
The transmission mode is also thought to be an important factor in predicting the outcome of HCV infection [36] . Based on a study among Egyptian children, Esmat, et al. [28] found that dental interventions were more likely to expose the patient to a high viral dose
